Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryGenome-based Drug DiscoveryArtificial IntelligenceAI Drug Discovery

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1500991

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1500991

Artificial Intelligence (AI) in Genomics

PUBLISHED:
PAGES: 210 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5800
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17400

Add to Cart

Description

Table of Contents

Global Artificial Intelligence (AI) in Genomics Market to Reach $7.7 Billion by 2030

The global market for Artificial Intelligence (AI) in Genomics estimated at US$703.5 Million in the year 2023, is expected to reach US$7.7 Billion by 2030, growing at a CAGR of 40.9% over the analysis period 2023-2030. AI in Genomics Software, one of the segments analyzed in the report, is expected to record a 44% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the AI in Genomics Services segment is estimated at 40% CAGR for the next 7-year period.

The U.S. Market is Estimated at $213.8 Million, While China is Forecast to Grow at 38% CAGR

The Artificial Intelligence (AI) in Genomics market in the U.S. is estimated at US$213.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 38% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 36.7% and 34.5% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 26.6% CAGR.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 23 Featured) -

  • Data4Cure
  • Deep Genomics
  • Fabric Genomics (formerly Omicia)
  • Freenome, Inc.
  • Genoox
  • IBM Corporation
  • Illumina, Inc.
  • Microsoft Corporation
  • NVIDIA Corporation
  • Sophia Genetics
Show more
Product Code: MCP23213

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Artificial Intelligence (AI) in Genomics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence (AI) in Genomics Market Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Artificial Intelligence (AI) in Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 4: World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2022, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 7: World 8-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 10: World 8-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 13: World 8-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Precision Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Precision Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 16: World 8-Year Perspective for Precision Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 19: World 8-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 22: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 25: World 8-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 28: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals & Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 31: World 8-Year Perspective for Hospitals & Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 34: World 8-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 37: World 8-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Machine Learning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Machine Learning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 40: World 8-Year Perspective for Machine Learning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 43: World 8-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 46: World 8-Year Perspective for Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Gene Editing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Gene Editing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 49: World 8-Year Perspective for Gene Editing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Other Functionalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Other Functionalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 52: World 8-Year Perspective for Other Functionalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 53: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 55: USA 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2024 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 58: USA 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2024 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 61: USA 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 64: USA 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2024 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 67: USA 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2024 & 2030
  • CANADA
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 70: Canada 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2024 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 73: Canada 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2024 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 76: Canada 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 79: Canada 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2024 & 2030
    • TABLE 80: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Canada Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 82: Canada 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2024 & 2030
  • JAPAN
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 85: Japan 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2024 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 88: Japan 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2024 & 2030
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 91: Japan 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 92: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Japan Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 94: Japan 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2024 & 2030
    • TABLE 95: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Japan Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 97: Japan 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2024 & 2030
  • CHINA
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 98: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 100: China 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2024 & 2030
    • TABLE 101: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 103: China 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2024 & 2030
    • TABLE 104: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: China Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 106: China 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 107: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: China Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 109: China 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2024 & 2030
    • TABLE 110: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: China Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 112: China 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2024 & 2030
  • EUROPE
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Artificial Intelligence (AI) in Genomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 115: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2022, 2024 & 2030
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 118: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2024 & 2030
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Europe Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 121: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2024 & 2030
    • TABLE 122: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Europe Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 124: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 125: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Europe Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 127: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2024 & 2030
    • TABLE 128: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Europe Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 130: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2024 & 2030
  • FRANCE
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 131: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: France Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 133: France 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2024 & 2030
    • TABLE 134: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: France Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 136: France 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2024 & 2030
    • TABLE 137: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: France Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 139: France 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 140: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: France Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 142: France 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2024 & 2030
    • TABLE 143: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: France Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 145: France 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2024 & 2030
  • GERMANY
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 146: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Germany Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 148: Germany 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2024 & 2030
    • TABLE 149: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Germany Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 151: Germany 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2024 & 2030
    • TABLE 152: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Germany Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 154: Germany 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 155: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Germany Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 157: Germany 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2024 & 2030
    • TABLE 158: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Germany Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 160: Germany 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2024 & 2030
  • ITALY
    • TABLE 161: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Italy Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 163: Italy 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2024 & 2030
    • TABLE 164: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Italy Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 166: Italy 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2024 & 2030
    • TABLE 167: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Italy Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 169: Italy 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 170: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Italy Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 172: Italy 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2024 & 2030
    • TABLE 173: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Italy Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 175: Italy 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2024 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 176: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: UK Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 178: UK 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2024 & 2030
    • TABLE 179: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: UK Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 181: UK 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2024 & 2030
    • TABLE 182: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: UK Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 184: UK 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 185: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: UK Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 187: UK 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2024 & 2030
    • TABLE 188: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UK Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 190: UK 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2024 & 2030
  • REST OF EUROPE
    • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Europe Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 193: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2024 & 2030
    • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Europe Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 196: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2024 & 2030
    • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Europe Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 199: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Europe Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 202: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2024 & 2030
    • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Europe Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 205: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2024 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 208: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2024 & 2030
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 211: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2024 & 2030
    • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 214: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 217: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2024 & 2030
    • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 220: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2024 & 2030
  • REST OF WORLD
    • TABLE 221: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Rest of World Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 223: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2024 & 2030
    • TABLE 224: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Rest of World Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 226: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2024 & 2030
    • TABLE 227: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of World Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 229: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 230: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of World Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 232: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2024 & 2030
    • TABLE 233: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of World Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 235: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!